New drug for HD approved in USA

Exciting news for the Huntington’s disease (HD) community! The USA drug regulator, the FDA, has approved a new drug in the treatment of HD. Its commercial name is Austedo, but the drug was previously known as Deutetrabenazine. It originates from Tetrabenazine which is used to treat chorea – the jerky movements – often found Read more…

Want to learn more about HD?

The Scottish Huntington`s Association in Collaboration With Stirling University are offering a webbased course in HD:  Huntington`s Disease; an enabling approach to supporting families.  You find more information about the wonderful opportunity here.